Companysuspendstradingafterdeath -China-Chinadaily.com.cn

2021年5月5日 by 没有评论

US
EUROPE
AFRICA
ASIAdocument.write(“” + m[today.getMonth()+1]+ ” “+ today.getDate()+”, ” + theYear + ” “);HOMECHINAWORLDBUSINESSLIFESTYLECULTURETRAVELSPORTSOPINIONREGIONALFORUMNEWSPAPERChina Daily PDFChina Daily E-paperChina Daily Global PDFChina Daily Global E-paperChina / Hot IssuesHot IssuesGovernmentSocietyInnovationEducationCover StoryPeoplePhotosCompany suspends trading after deathBy Zhu Wenqian (China Daily) Updated:2016-05-04 08:01Comments Print Mail Large Medium SmallA Shanghai-listed company suspended trading of its shares on Tuesday in the wake of the death of 21-year-old cancer patient Wei Zexi.The company, VCANBIO Cell & Gene Engineering Corp, issued a public statement in March on the acquisition of 100 percent of the equity in Shanghai Claison Bio-tech Co, with investment of 1.1 billion yuan ($170 million).Clasion provided immunotherapy technology services for the Second Hospital of the Beijing Armed Police Corps, where Wei received immunotherapy treatment.Wei learned about the treatment from search engine giant Baidu, but died last month from a rare form of cancer.Since news of his death broke, it has been impossible to access Clasions website, which is displaying the words “coming soon”.Asked if there was a connection between Clasion and the hospital, VCANBIOs general manager Wu Mingyuan said it was not possible to give a response at present and the company would release a statement later.Clasions main business involves research and development of cellular immunotherapy and providing technical services for medical institutions.The companys technical services for this therapy include using a patients own cells to fight cancer, and the controversy over Weis death centers on such therapy.Earlier, VCANBIO said it intends to acquire Kangxin Hospital Investment and Management Co. This hospital manages the domain name of the tumor diagnosis and biological treatment center of the Second Hospital of the Beijing Armed Police Corps.Clasion and Kangxin are both controlled by Chen Xinxi and Chen Xinxian from Putian, Fujian province.Another listed company saw its stocks plunge on Tuesday.Shares in Hua Xia Healthcare Holdings dropped by 13 percent to close at 53 Hong Kong cents ($0.06). The company is controlled by Weng Jiajin, the son of Putian businessman Weng Guoliang.Ji Xuwo, a healthcare analyst at Orient Securities in Beijing, said: “This case is expected to accelerate the launch of standardized regulations on the cellular therapy industry in China. The sector lacks supervision and quality control in specific clinical applications.”The private medical care system in China will in future focus on medical quality, and only those companies that can provide value for patients can achieve growth.”0PhotoNight views of Harbin through the lensTibetans take train home after pilgrimage or travellingWorlds largest shaftless Ferris wheel built in ChinaAncient cities to be connected by Xian-Chengdu high-speed railwaySnow turns Harbin into winter wonderlandReed Catkin Festival held in WuhanSocietyPoliticsHot TopicsScience/TechBusinessCover StoryFTZ simplifies process to launch businessesJapan can offer experience, expat saysApplication for work streamlinedAwareness of law aids resolutionAir Force units explore new airspaceLow wages and lack of respect responsible for kindergarten abuse, experts sayLiu heralds UK partnership in education and researchAgency ensuring natural gas supplyUN envoys trip to DPRK praised by BeijingChina moves to secure natural gas supply amid rising winter demandXi asks China, Canada to work for substantial tiesCooperation necessary for success, leaders sayLiving in space: How astronauts train, eat and workTeachers excused for lunchtime drinksWaiting for Shenzhou XICancer agent found in 44 cities drinking waterAt Ikea eatery, its no pay, no stayChina lose 2-0 to Uzbekistan in World Cup qualifier, coach Gao resignsC919 gains another 55 orders, lifting total orders to 785Services offset dip in manufacturingFintech to energize real economy, cut risksChinas Long March rockets complete 60 commercial launchesEngineers achieve breakthroughChina-made components add securityOnline shopping rings up customer complaintsImport expo to focus on advanced techSME mobile market platform receives first clientsChina top importer of US soybeansAir China opens direct route from Beijing to BarcelonaInsurance-based trust launchedDandelion helping to sow the seeds of stability for membersCover storyVisa change may boost tourism to USThe wrong side of the roadBuilding ban begins to biteVillagers call on Japan to atone for massacreMost ViewedTodays Top NewsNo letup in anti-graft fight, Xi warns Party ‘cabals and cliques’Families demand refunds for cancer treatmentEmirates launches flights between Yinchuan and DubaiHK needs to rehabilitate its tourist-friendly image: ExpertsFossil footprints bring dinosaurs to lifeMore than 15 pct of Chinas population are over 60Baidus share price drops after probe into search engine launchedBaidu faces probe after outcry over cancer treatmentPLA enlists rap-style music video to recruit young peopleHukou problem surfaces after an 11-year-old lie comes to lightA Chinese traffic cop prevents accidents thanks to his experience, winning praise from the world after a surveillance video was broadcasted by CNN.HighlightsBeijing students to learn traditional opera in schoolHome is where the heart is: Beijing car-hailing app drivers journeyAviation workers may face security checksFighting copyright infringement a constant battleHot TopicsGround level Rule of law Panda China youths Anti-terror drive Family planning Smog Fox Hunt Beijing integrates with Tianjin, Hebei China cracks down on graftSpecial2016 legislative and political advisory sessionsMy Chengdu story…| About China Daily | Advertise on Site | Contact Us | Job Offer | Expat Employment |Copyright 1995 -var oTime = new Date();
document.write(oTime.getFullYear());. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.License for publishing multimedia online 0108263             Registration Number: 130349      

Leave a Comment

邮箱地址不会被公开。 必填项已用*标注

1 + 15 =